Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma

Morton, 2006, Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001., Blood, 107, 265, 10.1182/blood-2005-06-2508

Dave, 2004, Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells., N Engl J Med, 351, 2159, 10.1056/NEJMoa041869

Cheung, 2010, Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis., Cancer Res, 70, 9166, 10.1158/0008-5472.CAN-10-2460

Stevenson, 2012, Follicular lymphoma and the immune system: from pathogenesis to antibody therapy., Blood, 119, 3659, 10.1182/blood-2011-11-367730

Relander, 2010, Prognostic factors in follicular lymphoma., J Clin Oncol, 28, 2902, 10.1200/JCO.2009.26.1693

Kridel, 2012, Pathogenesis of follicular lymphoma., J Clin Invest, 122, 3424, 10.1172/JCI63186

Negrini, 1987, Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma., Cell, 49, 455, 10.1016/0092-8674(87)90448-X

Tsujimoto, 1985, Involvement of the bcl-2 gene in human follicular lymphoma., Science, 228, 1440, 10.1126/science.3874430

Cleary, 1985, Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18., Proc Natl Acad Sci U S A, 82, 7439, 10.1073/pnas.82.21.7439

Leich, 2011, Pathology, pathogenesis and molecular genetics of follicular NHL., Best Pract Res Clin Haematol, 24, 95, 10.1016/j.beha.2011.02.003

Bende, 2007, Molecular pathways in follicular lymphoma., Leukemia, 21, 18, 10.1038/sj.leu.2404426

Ross, 2007, Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis., Clin Cancer Res, 13, 4777, 10.1158/1078-0432.CCR-07-0456

Fitzgibbon, 2007, Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma., Leukemia, 21, 1514, 10.1038/sj.leu.2404696

Eide, 2010, Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones., Blood, 116, 1489, 10.1182/blood-2010-03-272278

Cheung, 2010, High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes., Genes Chromosomes Cancer, 49, 669, 10.1002/gcc.20780

d’Amore, 2008, Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution., Clin Cancer Res, 14, 7180, 10.1158/1078-0432.CCR-08-0752

Höglund, 2004, Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas., Genes Chromosomes Cancer, 39, 195, 10.1002/gcc.10314

Henderson, 2004, Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6-megabase region of 6q16-q21., Genes Chromosomes Cancer, 40, 60, 10.1002/gcc.20013

Viardot, 2002, Clinicopathologic correlations of genomic gains and losses in follicular lymphoma., J Clin Oncol, 20, 4523, 10.1200/JCO.2002.12.006

Bentz, 1996, High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma., Blood, 88, 1437, 10.1182/blood.V88.4.1437.bloodjournal8841437

Yunis, 1987, Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer., N Engl J Med, 316, 79, 10.1056/NEJM198701083160204

Offit, 1993, 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin’s lymphoma., Blood, 82, 2157, 10.1182/blood.V82.7.2157.2157

Horsman, 2001, Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)., Genes Chromosomes Cancer, 30, 375, 10.1002/gcc.1103

Oricchio, 2011, The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma., Cell, 147, 554, 10.1016/j.cell.2011.09.035

Lohr, 2012, Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing., Proc Natl Acad Sci U S A, 109, 3879, 10.1073/pnas.1121343109

Puente, 2011, Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia., Nature, 475, 101, 10.1038/nature10113

Ngo, 2011, Oncogenically active MYD88 mutations in human lymphoma., Nature, 470, 115, 10.1038/nature09671

Chapman, 2011, Initial genome sequencing and analysis of multiple myeloma., Nature, 471, 467, 10.1038/nature09837

Lenz, 2008, Oncogenic CARD11 mutations in human diffuse large B cell lymphoma., Science, 319, 1676, 10.1126/science.1153629

Feng, 2011, IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools., J Immunol, 186, 1458, 10.4049/jimmunol.1001950

Pasqualucci, 2011, Inactivating mutations of acetyltransferase genes in B-cell lymphoma., Nature, 471, 189, 10.1038/nature09730

Mullighan, 2011, CREBBP mutations in relapsed acute lymphoblastic leukaemia., Nature, 471, 235, 10.1038/nature09727

Zhang, 2013, Genetic heterogeneity of diffuse large B-cell lymphoma., Proc Natl Acad Sci U S A, 110, 1398, 10.1073/pnas.1205299110

Morin, 2010, Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin., Nat Genet, 42, 181, 10.1038/ng.518

Green, 2013, Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma., Blood, 121, 1604, 10.1182/blood-2012-09-457283

Morin, 2011, Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma., Nature, 476, 298, 10.1038/nature10351

Launay, 2012, High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis., Leukemia, 26, 559, 10.1038/leu.2011.266

Fan, 2005, Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation., Cell, 123, 1199, 10.1016/j.cell.2005.10.028

Kim, 2012, Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription., Oncogene, 31, 4290, 10.1038/onc.2011.605

Yang, 2013, H1 linker histone promotes epigenetic silencing by regulating both DNA methylation and histone H3 methylation., Proc Natl Acad Sci U S A, 110, 1708, 10.1073/pnas.1213266110

Caterino, 2011, Structure of the H1 C-terminal domain and function in chromatin condensation., Biochem Cell Biol, 89, 35, 10.1139/O10-024

Clerc, 1988, The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains., Genes Dev, 2, 1570, 10.1101/gad.2.12a.1570

Scheidereit, 1988, A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein., Nature, 336, 551, 10.1038/336551a0

Klemm, 1994, Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules., Cell, 77, 21, 10.1016/0092-8674(94)90231-3

Assa-Munt, 1993, The solution structure of the Oct-1 POU-specific domain reveals a striking similarity to the bacteriophage lambda repressor DNA-binding domain., Cell, 73, 193, 10.1016/0092-8674(93)90171-L

Schubart, 2001, B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1., Nat Immunol, 2, 69, 10.1038/83190

Weigert, 2012, Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation., Cancer Discov, 2, 47, 10.1158/2159-8290.CD-11-0208

Jones, 2012, Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types., Hum Mutat, 33, 100, 10.1002/humu.21633

Schmitz, 2009, TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma., J Exp Med, 206, 981, 10.1084/jem.20090528

Pasqualucci, 2014, Genetics of follicular lymphoma transformation., Cell Rep, 6, 130, 10.1016/j.celrep.2013.12.027

Morin, 2013, Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing., Blood, 122, 1256, 10.1182/blood-2013-02-483727

Godde, 2008, Cracking the enigmatic linker histone code., J Biochem, 143, 287, 10.1093/jb/mvn013

Jones, 2010, Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma., Science, 330, 228, 10.1126/science.1196333

Duan, 2008, Functional long-range interactions of the IgH 3′ enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells., Oncogene, 27, 6720, 10.1038/onc.2008.286

Heckman, 2006, Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression., Oncogene, 25, 888, 10.1038/sj.onc.1209127

Emslie, 2008, Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells., J Exp Med, 205, 409, 10.1084/jem.20072049

Turcotte, 2005, A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice., J Exp Med, 201, 881, 10.1084/jem.20042170